Immuron Travelan® continued strong sales growth

4 weeks ago

MELBOURNE, Australia, Oct. 15, 2024 ( GLOBE NEWSWIRE ) -- Immuron Limited ( ASX: IMC. NASDAQ: IMRN ) , an Australian based and globally integrated biopharmaceutical company is pleased to announce continued strong sales growth ( unaudited ) of Travelan®, an over-the-counter immune supplement that ...

Ticker	Sentiment	Impact
IMRN	Neutral	30 %